跳至主要内容
临床试验/NCT01888198
NCT01888198进行中(未招募)不适用

Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment

Memorial Sloan Kettering Cancer Center6 个研究点 分布在 1 个国家目标入组 294 人开始时间: 2013年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
294
试验地点
6
主要终点
assess renal ablation outcomes

研究概览

简要总结

The purpose of this study is to better understand how effective ablation is for destroying tumor cells in the kidney and whether quality of life is improved for patients. Participation in ARMOR may involve retrospective data collection only, combined retrospective and prospective data collection, or prospective data collection

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Retrospective enrollment:
  • - Patients having undergone percutaneous, open or laparoscopic energy ablation of a renal mass.
  • Prospective enrollment:
  • - Patients scheduled to undergo, rather than having undergone, percutaneous, open or laparoscopic energy ablation of a renal mass.

排除标准

  • Patients not having undergone, or considered candidates for percutaneous, open or laparoscopic energy ablation of a renal mass
  • Non-English speaking patients
  • Patients under the age of 18.

结局指标

主要结局

assess renal ablation outcomes

时间窗: 5 years

To assess renal ablation outcomes using standard quality of life measures. Specifically, quality of life outcomes measures will be analyzed with respect to ablation procedure characteristics including ablation technique and anesthesia type as well as renal mass characteristics such as size, location and pathologic tumor type.

次要结局

  • differences in imaging characteristics(5 years)
  • Assess the progression of imaging findings(5 years)
  • Radiation exposure(5 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验